$4.54
Cingulate is a biotechnology business based in the US. Cingulate shares (CING) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.92 – an increase of 10.56% over the previous week. Cingulate employs 13 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Cingulate stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Cingulate stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CING. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cingulate stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cingulate stock price (NASDAQ: CING)
Use our graph to track the performance of CING stocks over time.Cingulate shares at a glance
Latest market close | $4.92 |
---|---|
52-week range | $1.80 - $152.40 |
50-day moving average | $6.06 |
200-day moving average | $15.94 |
Wall St. target price | $80.33 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-326.40 |
Is it a good time to buy Cingulate stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cingulate price performance over time
Historical closes compared with the close of $4.59 from 2024-10-18
1 week (2024-10-16) | 4.32% |
---|---|
1 month (2024-09-23) | -10.35% |
3 months (2024-07-23) | 1,166.56% |
6 months (2024-04-23) | 422.36% |
1 year (2023-10-23) | 836.73% |
---|---|
2 years (2022-10-21) | 309.82% |
3 years (2021-10-19) | N/A |
5 years (2019-10-19) | N/A |
Cingulate financials
Gross profit TTM | $-8,995,280 |
---|---|
Return on assets TTM | -225.77% |
Return on equity TTM | -1364.73% |
Profit margin | 0% |
Book value | $3.95 |
Market Capitalization | $14.7 million |
TTM: trailing 12 months
Cingulate share dividends
We're not expecting Cingulate to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (5.74% forward annual dividend yield)
- Johnson-and-Johnson (JNJ.US) (3% forward annual dividend yield)
- Eli Lilly and Company (LLY.US) (0.57% forward annual dividend yield)
Have Cingulate's shares ever split?
Cingulate's shares were split on a 1:12 basis on 8 August 2024 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cingulate shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Cingulate shares which in turn could have impacted Cingulate's share price.
Cingulate share price volatility
Over the last 12 months, Cingulate's shares have ranged in value from as little as $1.8001 up to $152.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cingulate's is -0.934. This would suggest that Cingulate's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cingulate has bucked the trend.
To put Cingulate's beta into context you can compare it against those of similar companies.
- Pfizer (PFE.US): 0.617
- Johnson-and-Johnson (JNJ.US): 0.518
- Eli Lilly and Company (LLY.US): 0.416
Cingulate overview
Cingulate Inc. , a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas. .
Frequently asked questions
nullWhat percentage of Cingulate is owned by insiders or institutions?
Currently 3.482% of Cingulate shares are held by insiders and 2.636% by institutions. How many people work for Cingulate?
Latest data suggests 13 work at Cingulate. When does the fiscal year end for Cingulate?
Cingulate's fiscal year ends in December. Where is Cingulate based?
Cingulate's address is: 1901 West 47th Place, Kansas City, KS, United States, 66205 What is Cingulate's ISIN number?
Cingulate's international securities identification number is: US17248W1053
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question